Background: Deep learning image reconstruction (DLIR) and adaptive statistical iterative reconstruction-V (ASIR-V) has been used for cardiac computed tomography imaging. However, DLIR and ASIR-V may influence the quantification of coronary artery calcification (CAC). Methods: CT images of 96 patients were reconstructed using filtered back projection (FBP), ASIR-V 50%, and three levels of DLIR [low (L), medium (M), and high (H)]. Image noise and the Agatston, volume, and mass scores were compared between the reconstructions. Patients were stratified into six Agatston score-based risk categories and five CAC percentile risk categories adjusted by Agatston score, age, sex, and race. The number of patients who were switched to another risk stratification group when ASIR-V and DLIR were used was compared. Bland-Altman plots were used to present the agreement of Agatston scores between FBP and the different reconstruction techniques. Results: Compared to that with FBP, image noise was significantly decreased with ASIR-V 50%, and DLIR-L, -M, and -H (all P<0.001). The Agatston, volume, and mass scores with ASIR-V 50% and DLIR-L, -M, and -H showed significant decreases in comparison to those calculated with FBP (all P0.05). Conclusions: DLIR and ASIR-V show great potential for improving CT image quality, and appear to have no pronounced impact on CAC quantification or Agatston score-based risk stratification.
12 April 2022 in Frontiers in Bioengineering and Biotechnology
Purpose: While radiotherapy remains the leading clinical treatment for many tumors, its efficacy can be significantly hampered by the insensitivity of cells in the S phase of the cell cycle to such irradiation.Methods: Here, we designed a highly targeted drug delivery platform in which exosomes were loaded with the FDA-approved anti-tumor drug camptothecin (CPT) which is capable of regulating cell cycle. The utilized exosomes were isolated from patient tumors, enabling the personalized treatment of individuals to ensure better therapeutic outcomes.Results: This exosome-mediated delivery strategy was exhibited robust targeted to patient-derived tumor cells in vitro and in established patient-derived xenograft models. By delivering CPT to tumor cells, this nanoplatform was able to decrease cell cycle arrest in the S phase, increasing the frequency of cells in the G1 and G2/M phases such that they were more radiosensitive.Conclusion: This therapeutic approach was able to substantially enhance the sensitivity of patient-derived tumors to ionizing radiation, thereby improving the overall efficacy of radiotherapy without the need for a higher radiation dose.
In participants with rectal cancer, portal venous abdominal photon-counting detector CT at 40 keV and with quantum iterative reconstruction–4 optimized image quality, potentially enhanced T-staging diagnostic performance, and performed similarly to MRI.
Radiologists assisted by the proposed sham–artificial intelligence (AI) model, acting as a placebo control for a standard-AI model to mitigate biases in intracranial aneurysm diagnosis, had noninferior sensitivity and specificity compared with radiologists alone.
Bridgeless Boost PFC converters have drawn attentions due to higher efficiency than traditional Boost PFC converter. There are a variety of control schemes for bridgeless Boost PFC converters. Hysteresis current control scheme is good solution owing to easy to control and good robustness. It is well known that switch frequency variation range would be large to make filter difficultly designed if the algorithm is used. Asymmetric dynamic window current hysteresis control scheme is put forward to make up for deficiency. Simulation results show the scheme is less frequency variation range than the basic hysteresis control scheme.
Objectives: Differentiating chronic total occlusion (CTO) from subtotal occlusion (SO) is often difficult to make from coronary computed tomography angiography (CCTA). We developed a CCTA-based radiomics model to differentiate CTO and SO. Methods: A total of 66 patients with SO underwent CCTA before invasive angiography and were matched to 66 patients with CTO. Comprehensive imaging analysis was conducted for all lesioned vessels, involving the automatic identification of the lumen within the occluded segment and extraction of 1,904 radiomics features. Radiomics models were then constructed to assess the discriminative value of these features in distinguishing CTO from SO. External validation of the model was performed using data from another medical center. Results: Compared to SO patients, CTO patients had more blunt stumps (internal: 53/66 (80.3%) vs. 39/66 (59.1%); external: 36/50 (72.0%) vs. 20/50 (40.0%), both p < 0.01), longer lesion length (internal: median length 15.4 mm[IQR: 10.4-22.3 mm] vs. 8.7 mm[IQR: 4.9-12.6 mm]; external:11.8 mm[IQR: 6.1-23.4 mm] vs. 6.2 mm[IQR: 3.5-9.1 mm]; both p < 0.001). Sixteen unique radiomics features were identified after the least absolute shrinkage and selection operator regression. When added to the combined model including imaging features, radiomics features provided increased value for distinguishing CTO from SO (AUC, internal: 0.772 vs. 0.846; p = 0.023; external: 0.718 vs. 0.781, p = 0.146). Conclusions: The occluded segment vessels of CTO and SO have different radiomics signatures. The combined application of radiomics features and imaging features based on CCTA extraction can enhance diagnostic confidence.